People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, ...

People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, ...

Bladder cancer ranks among the ten most common types of cancer worldwide. The main treatment is bladder removal surgery, and despite advances in systemic therapies, recurrence is frequent in the most ...

EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free ...

A cancer clinical trial of ivermectin is included in plans for a state-funded medical research program in Florida. (Washington Post) A new startup focuses on developing oral cancer drugs that release ...

Life expectancy is back to pre-pandemic levels, according to global health research — but mortality rates for teens and young adults are of growing concern. The latest release of The Global Burden of ...

BOSTON, October 12, 2025 – Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for ...

(CNN) — Humans are living 20 years longer than they were in 1950, according to new research with all 204 countries and territories studied reporting declines in their mortality rates since then. But ...

Experts argue it's never too late to quit smoking, and a new study says that applies to people with late-stage cancer as well. Patients with advanced cancer gained nearly a full year of additional ...

People with Duchenne muscular dystrophy (DMD) frequently live well into adulthood. Advances in treatment have significantly increased the life expectancy for this condition. The median life expectancy ...

Chicago’s average life expectancy bounced back to 78.7 years in 2023, nearly hitting its prepandemic peak — though large gaps remain between races and neighborhoods, according to the city health ...

NEW YORK CITY — The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of bladder cancer, the drugmaker said on Tuesday, offering a ...